Seeing Is Believing
Currently out of the existing stock ratings of Yatin Suneja, 130 are a BUY (83.87%), 25 are a HOLD (16.13%).
Analyst Yatin Suneja works at GUGGENHEIM with a stock forecast success ratio of 41.11% fulfilled within 187.89 days on average.
Yatin Suneja’s has documented 343 price targets and ratings displayed on 40 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CLDX, Celldex Therapeutics at 27-Feb-2024.
Analyst best performing recommendations are on IMVT (IMMUNOVANT ).
The best stock recommendation documented was for IMVT (IMMUNOVANT ) at 9/22/2023. The price target of $32 was fulfilled within 4 days with a profit of $11.61 (56.94%) receiving and performance score of 142.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
25
$8.41 (50.69%)
29
1 months ago
5/8 (62.5%)
$7.16 (40.13%)
26
Buy
30
$13.41 (80.83%)
40
1 months 12 days ago
16/19 (84.21%)
$10.44 (53.37%)
184
Buy
39
$22.41 (135.08%)
40
1 months 28 days ago
6/10 (60%)
$15.25 (64.21%)
94
Buy
33
$16.41 (98.92%)
33
1 months 28 days ago
8/19 (42.11%)
$9.25 (38.95%)
119
Buy
36
$19.41 (117.00%)
1 months 28 days ago
0/1 (0%)
$12.25 (51.58%)
Which stock is Yatin Suneja is most bullish on?
Which stock is Yatin Suneja is most reserved on?
What Year was the first public recommendation made by Yatin Suneja?